PDL

DEVICE5 trials

Sponsors

Boston University, Massachusetts General Hospital, Endo Pharmaceuticals, Universitätsklinikum Hamburg-Eppendorf, Second Affiliated Hospital of Xi'an Jiaotong University

Conditions

CelluliteCicatrixEdematous Fibrosclerotic Panniculopathy (EFP)Laryngeal PapillomaPort-Wine Stain

Phase 2

Celebrex (Celecoxib) Treatment of Laryngeal Papilloma

TerminatedNCT00592319

Boston UniversityLaryngeal Papilloma

Start: 2005-05-31End: 2009-07-31Updated: 2012-08-31

Phase 4

Effects of Mitigation Treatments on Bruising of CCH-aaes Treatment of Buttock Cellulite

CompletedNCT04677712

Endo PharmaceuticalsCellulite, Edematous Fibrosclerotic Panniculopathy (EFP)

Start: 2020-12-28End: 2021-09-02Updated: 2023-08-21

Unknown Phase

Pulsed-dye Laser Treatment Prior to Surgical Excision

Massachusetts General HospitalCicatrix

Start: 2015-06-30End: 2018-07-31Target: 20Updated: 2017-04-20

KTP Laser vs Pulsed Dye Laser for Port-Wine Stains

Universitätsklinikum Hamburg-EppendorfPort-Wine Stain

Start: 2023-02-01End: 2023-08-01Target: 30Updated: 2023-03-16

Retrospective Cohort Study on the Impact of PDL Treatment History on the Efficacy of HMME-PDT in Treating PWS Children

CompletedNCT06875492

Second Affiliated Hospital of Xi'an Jiaotong UniversityPort-Wine Stain

Start: 2024-04-01End: 2024-09-01Updated: 2025-03-13